Navigation Links
Risk-based Approach to Monitoring: Deployment Insights and Lessons Learned, New Xtalks Webinar
Date:4/5/2013

Toronto, Canada (PRWEB) April 05, 2013

Bringing a therapy to market can cost billions. Now with support from the FDA and EMA, the industry is ready to realize the promise of risk-based monitoring.

By integrating best practices from RBM studies with new approaches and innovative technology, Mr. Dan White, Vice-President of Global Operations at Quintiles, will share common challenges, lessons learned, and how to best apply processes and technology to deliver the optimal outcome for a study.

Specifically, this webinar will explore how to:

  •     Apply risk analysis to each study to evaluate the scientific and operational risk of each protocol
  •     Identify the optimal monitoring approach for each study
  •     Integrate dynamic monitoring and data analysis for faster identification of patient and study issues
  •     Place resources for optimal execution
  •     Leverage on-demand insights to implement risk-based processes and workflows compatible with a global regulatory requirements

For more information about this event or to register, visit: http://xtks.in/xto576-event

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/4/prweb10599131.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Site Quality Management to Optimize Risk-Based and Centralized Monitoring, New Life Science Webinar Hosted by Xtalks
2. Challenges and Opportunities in Risk-Based Monitoring, New Webinar Hosted by Xtalks
3. Neighborhood Smiles of Green Bay Offers a New Approach to the Cavity Epidemic
4. Local Dentist is Saving Lives with His Cutting-Edge Approach to Dental Caries
5. Strategic Approach for R&D Is Goal at National Photonics Initiative Event Co-Sponsored by SPIE
6. Quantum Cures Announces Breakthrough Approach for Researchers Seeking Cures for Orphan and Rare Diseases
7. Local Dentist is Saving Lives with her Cutting Edge Approach to Dental Caries
8. Cost-Effective Approaches to Quality Distribution and Logistics for Temperature Sensitive Products
9. Bottom-up approach provides first characterization of pyroelectric nanomaterials
10. Trudeau Institute Awarded Grant to Investigate a New Approach to Treating Illnesses Caused by Weaponized and Antibiotic-Resistant Bacteria
11. ViThera Novel Approach Using Probiotics to Deliver Elafin Shows Promise as a Future Inflammatory Bowel Disease (IBD) Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):